Home/Filings/4/0001209191-11-041203
4//SEC Filing

Bradford Williamson Z III 4

Accession 0001209191-11-041203

CIK 0001087432other

Filed

Jul 26, 8:00 PM ET

Accepted

Jul 27, 9:46 PM ET

Size

8.7 KB

Accession

0001209191-11-041203

Insider Transaction Report

Form 4
Period: 2011-07-27
Bradford Williamson Z III
SVP-Clinical Science
Transactions
  • Sale

    Common Stock

    2011-07-27$35.16/sh1,800$63,28661,577 total
  • Exercise/Conversion

    Common Stock

    2011-07-27$8.73/sh+1,800$15,71463,377 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-07-271,80079,700 total
    Exercise: $8.73Exp: 2020-06-08Common Stock (1,800 underlying)
Footnotes (3)
  • [F1]These transactions were made pursuant to a 10b5-1 trading plan entered into in the fourth quarter of 2010 and in effect at the time of the transactions. The transactions were pre-determined in the trading plan to occur at specific dates and share prices of InterMune.
  • [F2]Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $35 to $35.54 per share. Full information on the numbers of shares sold at each sale price is available upon request.
  • [F3]33.3334% of the total number of shares subject to the stock option vest and become exercisable cumulatively on each of the following dates: June 8, 2011, December 8, 2011 and June 8, 2012.

Issuer

INTERMUNE INC

CIK 0001087432

Entity typeother

Related Parties

1
  • filerCIK 0001306194

Filing Metadata

Form type
4
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 9:46 PM ET
Size
8.7 KB